Blood bank reagents
Ended Awarded Last action
- Contract number
- 36C24425N0005
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $125,089
Award facts
- Contract value 100% obligated
- $125,089.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15240, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$39,603 | |
| Supplemental Agreement for work within scope | $350 | |
| Supplemental Agreement for work within scope | $5,865 | |
| Original award | $158,477 |
About this award
Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory reagents, was awarded a $125,089.48 firm fixed-price Blanket Purchase Agreement (BPA) call by the Department of Veterans Affairs' Veterans Integrated Service Network 4 for blood bank reagents. The contract, awarded on October 1, 2024, with an ultimate completion date of September 30, 2025, will be performed in Pittsburgh, Pennsylvania. This award does not include a small business set-aside designation, reflecting Werfen's status as a full-sized federal contractor. The award falls under the company's parent contract vehicle, the In Vitro Diagnostics, Reagents, and Test General Services Administration Schedule (FSS-65-VII).
This BPA call represents another addition to Werfen's extensive portfolio of federal healthcare contracts, particularly with the VA system, where the company has established multiple significant contract vehicles for diagnostic testing services and equipment across various Veterans Integrated Service Networks. Werfen's blood bank reagent supplies support critical laboratory operations within the VA's healthcare delivery system, enabling clinical laboratories to conduct essential diagnostic testing for veteran patients. The firm fixed-price structure ensures predictable costs for the contracting agency while leveraging the established BPA framework for efficient procurement of specialized laboratory consumables.
Quick answers
Who was awarded contract 36C24425N0005?
36C24425N0005 was awarded to Werfen USA LLC by Veterans Integrated Service Network 4 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C24425N0005 worth?
The government has obligated $125,089 on 36C24425N0005.
Is contract 36C24425N0005 an order under another contract?
Yes. 36C24425N0005 is a BPA call under V797D70110-36C24421A0067, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C24425N0005 competed?
The extent of competition for 36C24425N0005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award